Related Experiment Video
Updated: May 18, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation
Fuminori Tokunaga1, Hiroshi Nishimasu, Ryuichiro Ishitani
1Laboratory of Molecular Cell Biology, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan. ftokunaga@gunma-u.ac.jp
Insights
A20 protein suppresses NF-κB activation by binding linear ubiquitin chains, revealing new insights into immune and inflammatory response regulation. This mechanism involves A20
Area of Science:
- Molecular Biology
- Immunology
- Structural Biology
Background:
- The linear ubiquitin chain assembly complex (LUBAC) activates the canonical NF-κB pathway.
- The precise regulatory mechanisms governing LUBAC-mediated NF-κB activation are not fully understood.
Purpose of the Study:
- To elucidate the regulatory mechanisms of LUBAC-mediated NF-κB activation.
- To investigate the roles of A20 and CYLD in suppressing this pathway.
Main Methods:
- Determined crystal structures of A20's seventh zinc finger (ZF7) in complex with linear diubiquitin.
- Utilized functional analysis to assess the impact of A20 binding on NF-κB signaling.
- Investigated the deubiquitinase (DUB) activity of CYLD.
Main Results:
- A20 suppresses LUBAC-mediated NF-κB activation by binding linear polyubiquitin via its ZF7 domain.
- Crystal structures reveal A20 ZF7 simultaneously recognizes Met1-linked ubiquitins, with disease-associated mutations mapping to these sites.
- A20 binding to linear polyubiquitin facilitates its recruitment into TNF receptor signaling complexes, inhibiting NF-κB activation.
Conclusions:
- A20 directly inhibits LUBAC-mediated NF-κB activation through specific binding to linear ubiquitin chains.
- CYLD also suppresses this pathway via its deubiquitinase activity.
- These findings offer novel insights into the regulation of immune and inflammatory responses.
Abstract:
LUBAC (linear ubiquitin chain assembly complex) activates the canonical NF-κB pathway through linear polyubiquitination of NEMO (NF-κB essential modulator, also known as IKKγ) and RIP1. However, the regulatory mechanism of LUBAC-mediated NF-κB activation remains elusive. Here, we show that A20 suppresses LUBAC-mediated NF-κB activation by binding linear polyubiquitin via the C-terminal seventh zinc finger (ZF7), whereas CYLD suppresses it through deubiquitinase (DUB) activity. We determined the crystal structures of A20 ZF7 in complex with linear diubiquitin at 1.70-1.98 Å resolutions. The crystal structures revealed that A20 ZF7 simultaneously recognizes the Met1-linked proximal and distal ubiquitins, and that genetic mutations associated with B cell lymphomas map to the ubiquitin-binding sites. Our functional analysis indicated that the binding of A20 ZF7 to linear polyubiquitin contributes to the recruitment of A20 into a TNF receptor (TNFR) signalling complex containing LUBAC and IκB kinase (IKK), which results in NF-κB suppression. These findings provide new insight into the regulation of immune and inflammatory responses.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors

